Abstract
Using an unbiased genetic screen, To etal. map genes that enhance or suppress growth defects in response to different mitochondrial inhibitors to model mitochondrial disease. The findings have novel implications for the interconnectivity of bioenergetic pathways, and suggest a provocative strategy to treat primary mitochondrial disorders.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have